川芎嗪的结构修饰及生物活性

介绍了川芎嗪的结构修饰及其衍生物的生物活性、川芎嗪衍生物合成及其在新药开发方面的发展前景。     

The electrochemistry and determination of Ligustrazine hydrochloride

Ligustrazine is one of the active ingredients contained in Ligusticum chuanxiong Hort. (Umbelliferae), which is widely used in traditional Chinese medicine for the treatment of cardiovascular problems. In this work, the electrochemistry of Ligustrazine hydrochloride (LZC) and its determination are investigated. The detection limit is estimated to be 8.0×10^–8 M, with three linear ranges from 1.0×10^–6 to 1.0×10^–4 M, 1.0×10^–4 to 5.0×10^–4 M, and 6.5×10^–4 to 1.6×10^–3 M. The method has been proved to be highly sensitive, selective, and stable, and has been successfully applied to determining LZC in LZC injections.     

三维荧光二阶校正法用于复杂基体样中川芎嗪和替米沙坦的快速定量分析

采用三维荧光光谱法,结合化学计量学中基于交替归一加权残差(ANWE)算法的二阶校正方法,实现了人血浆样品中川芎嗪和替米沙坦的同时快速定量分析.当组分数N取4时,ANWE算法解析获得的川芎嗪和替米沙坦的平均回收率分别为99.3士3.5%和96.8±2.0%.本文同时给出了此方法的检测限(LOD)与定量下限(LOQ),获得...     

Synthesis and NHE1 inhibitory activity of ligustrazine derivatives

A series of novel derivatives of ligustrazine linked with substituted benzoyl guanidine were synthesized. These compounds have not been reported in literature, and their chemical structures were confirmed by IR, 1H NMR and MS. The results of NHE1 inhibitory activity test showed that compounds I2, I3, I4, I6, and I7 possess more potent NHE1 inhibitory activity than cariporide.     

吡嗪类化合物的合成及其抗血小板凝集活性测试

为提高川芎嗪的抗血小板凝集活性,分别以不同的二胺、2,3-丁二酮和硫辛酸为起始原料,采用溴代、水解、环化、氧化、氢化、取代等反应,通过四条路线合成了7个川芎嗪衍生物,其结构经1H NMR、13C NMR及ESI-MS确证。采用Born比浊法初步测试了化合物的体外抗血小板凝集活性,结果显示,化合物1(IC50=0. 26mmol/L)、2(IC50=0. 27mmol/L)和7(IC50=0. 21mmol/L)对由二磷酸腺苷(ADP)诱导的血小板凝集具有一定的抑制活性,优于先导化合物川芎嗪(IC50=0. 49mmol/L)。因此,在不改变川芎嗪药效团的前提下对其进行不同程度的环化,能明显提高川芎嗪的抗血小板凝集活性,此研究为后期化合物的结构修饰提供了一定的参考价值。     

盐酸川芎嗪的荧光光谱研究及应用

在 p H6— 10的水溶液中 ,盐酸川芎嗪产生稳定的荧光。最佳激发波长与发射波长分别为 2 95nm和335nm,当盐酸川芎嗪浓度为 5.0× 10 -6— 5.0× 10 -5mol/ L时 ,荧光强度与浓度有良好的线性关系。据此建立了荧光光度法直接测定盐酸川芎嗪注射液中盐酸川芎嗪含量的方法 ,该方法的相对标准偏差为3.51% ,检出下限为 1.0× 10 -6mol/ L。     

川芎嗪衍生物的设计、合成及抗血小板凝集活性研究

分别以川芎嗪(TMP)和邻苯二胺为起始原料,经KMn O4氧化、酯缩合、环化、还原等步骤合成了7个新型的川芎嗪衍生物,其结构经1H NMR、13C NMR及HRMS确证。并采用Born比浊法初步测试了化合物的体外抗血小板凝集活性。结果表明,化合物3和7对二磷酸腺苷(ADP)诱导的血小板凝集抑制率IC50分别为0.23mmol/L和0.27mmol/L,优于母体化合物川芎嗪(0.42mmol/L)。     

Preparation of molecularly imprinted adsorptive resin for trapping of ligustrazine from the traditional Chinese herb Ligusticum chuanxiong Hort

A highly selective molecularly imprinted adsorptive resin for ligustrazine was prepared by melamine-urea-formaldehyde (MUF) gel. In the experiments, two pieces of MUF gel were synthesized firstly; one was added ligustrazine hydrochloride as the template molecule in it to prepare the imprinted adsorptive resin, and the other was not. Scanning electron microscopy (SEM) revealed that both resins were the porous with a network structure whether or not it was added template molecule. The imprinted adsorptive resin had an absorbability of 85.22% measured by a 200 mg L⁻¹ solution of ligustrazine hydrochloride at room temperature. The resin of MUF without template, on the other hand, displayed an adsorption capacity of almost zero. It illuminated the imprinted adsorptive resin formed ligustrazine recognition sites when the template molecule had been eluted. In the present paper, ligustrazine was effectively separated and enriched from herbs by using a solid-phase adsorptive column filled with the imprinted adsorptive resin. Its eluate, obtained from three kinds of solvents, was analyzed by GC-MS, and the results indicated that the imprinted adsorptive resin showed a high selectivity for ligustrazine. This is believed to be beneficial for extracting natural and highly purified ligustrazine.     

盐酸川芎嗪在玻碳电极上的伏安行为及应用

对盐酸川芎嗪在玻碳电极上的伏安行为进行了研究 ,在 0 .0 1mol LKCl～HCl(pH 2 .2 )底液中盐酸川芎嗪于 -0 .5 5V处产生良好的阴极还原峰 ,其浓度在 1 0× 1 0 - 6 ～ 1 .0× 1 0 - 4mol L范围内与峰电流呈线性关系。该方法具有很强的抗干扰能力 ,操作简便、快速。用于注射液中盐酸川芎嗪的测定 ,结果满意。对电极反应机理也进行了探讨。